Unlock instant, AI-driven research and patent intelligence for your innovation.

A kind of method that microchannel reactor synthesizes crizotinib intermediate

A microchannel reactor, a technology for synthesizing crizotinib, applied in chemical instruments and methods, chemical/physical/physical-chemical reactors, organic chemistry, etc. Chlorine side reaction and other problems, to achieve the effect of stable online production and post-treatment, production economic guarantee, and production cost reduction

Active Publication Date: 2021-03-30
HEILONGJIANG XINCHUANG BIOLOGICAL TECH DEV CO LTD
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0008] In order to solve the problems of low yield and low purity in the synthesis process of traditional high-pressure catalytic hydrogenation reactors, the danger of violent explosions, the long reaction time at high temperatures resulting in dechlorination side reactions, and the low rate of catalyst recovery and application, the present invention provides An intrinsically safe and environmentally friendly catalytic hydrogenation synthesis technology for 3-(1-(2,6-dichloro-3-fluorophenyl)ethoxy)pyridin-2-amine, which utilizes microchannel reaction for the first time The device (also known as microreactor) technology has completed a catalytic hydrogenation reaction to synthesize the intermediate 3-(1-(2,6-dichloro-3-fluorophenyl)ethoxy)pyridine- The method of 2-amine, chemical reaction formula is as follows:

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A kind of method that microchannel reactor synthesizes crizotinib intermediate
  • A kind of method that microchannel reactor synthesizes crizotinib intermediate
  • A kind of method that microchannel reactor synthesizes crizotinib intermediate

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0039] This embodiment provides a method for the synthesis of crizotinib intermediates in a microchannel reactor, such as figure 1 with figure 2 As shown, the microchannel reactor used includes a preheating module, a reaction module group and a cooling module, wherein: the preheating module is connected in series with the reaction module group, the cooling module is connected in series with the reaction module group, and the reaction module group includes a unit reaction module Or be formed by the serial combination of more than two unit reaction modules; The synthetic method of 2-amino-5-chlorobenzophenone comprises the following steps:

[0040] 1) Weigh 200g of raw material 3-(1-(2,6-dichloro-3-fluorophenyl)ethoxy)-2-nitropyridine, then add it to the mixture of 2L methanol and 2L ethyl acetate In the liquid, after stirring and dissolving, add 10g of Pt / C catalyst with a mass content of 5% and fully stir and mix to form material I, which is transported to the preheating mo...

Embodiment 2

[0043] This embodiment provides a method for the synthesis of crizotinib intermediates in a microchannel reactor, such as figure 1 with figure 2 As shown, the microchannel reactor used includes a preheating module, a reaction module group and a cooling module, wherein: the preheating module is connected in series with the reaction module group, the cooling module is connected in series with the reaction module group, and the reaction module group includes a unit reaction module Or be formed by the serial combination of more than two unit reaction modules; The synthetic method of 2-amino-5-chlorobenzophenone comprises the following steps:

[0044] 1) Weigh 250g of the raw material 3-(1-(2,6-dichloro-3-fluorophenyl)ethoxy)-2-nitropyridine, and add it to a mixture of 2.5L methanol and 2.5L tetrahydrofuran In, after stirring and dissolving, add 12g of Pt / C catalyst with a mass content of 6% to fully stir and mix to form material I, and material I is transported to the preheatin...

Embodiment 3

[0047] This embodiment provides a method for the synthesis of crizotinib intermediates in a microchannel reactor, such as figure 1 with figure 2 As shown, the microchannel reactor used includes a preheating module, a reaction module group and a cooling module, wherein: the preheating module is connected in series with the reaction module group, the cooling module is connected in series with the reaction module group, and the reaction module group includes a unit reaction module Or be formed by the serial combination of more than two unit reaction modules; The synthetic method of 2-amino-5-chlorobenzophenone comprises the following steps:

[0048] 1) Weigh 180g of the raw material 3-(1-(2,6-dichloro-3-fluorophenyl)ethoxy)-2-nitropyridine, and add it to a mixture of 1.8L of ethanol and 1.8L of acetonitrile In, after stirring and dissolving, add 15g of Pd / C catalyst with a mass content of 8% and fully stir and mix to form material I. Material I is transported to the preheating...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a method for synthesizing a crizotinib intermediate in a microchannel reactor and belongs to the technical field of anticancer drug synthesis in organic synthesis. The method comprises adding 3-(1-(2, 6-dichloro-3-fluorophenyl)ethoxy)-2-nitropyridine into an organic solvent, adding an activated carbon-loaded noble metal catalyst into the solution to obtain a material I, conveying the material I into a preheating module of a microchannel reactor, carrying out preheating, respectively conveying the preheated material I and hydrogen into a reaction module of the microchannel reactor, carrying out a reaction process, collecting the reaction liquid from the outlet of the microchannel reactor and carrying out aftertreatment to obtain 3-(1-(2, 6-dichloro-3-fluorophenyl)ethoxy)pyridine-2-amine. The method can effectively shorten the reaction time, reduce energy consumption, save a cost, improve product quality, greatly reduces the potential safety hazard of hydrogen leakage, combustion and explosion and is suitable for the synthesis of crizotinib intermediates.

Description

technical field [0001] The invention relates to a method for synthesizing a crizotinib intermediate in a microchannel reactor, and belongs to the technical field of anticancer drug synthesis in organic synthesis. Background technique [0002] Crizotinib is an anticancer drug developed by GlaxoSmithKline. Its chemical name is 3-[(1R)-1-(2,6-dichloro-3-fluorophenyl)ethoxy]-5-[1 -(4-piperidine)-1H-pyrazol-4-yl]-2-pyridinamine, the chemical structure is as follows: [0003] [0004] The drug was developed by Pfizer of the United States and approved by the FDA in 2011. It is the first ALK tyrosine kinase receptor inhibitor approved by the FDA for phase III clinical trials. The invention and application of this drug represent a major breakthrough in individualized treatment, another milestone in the development of new anticancer drugs, and the drug of choice for first-line treatment of ALK-positive non-small cell lung cancer. [0005] The structure of crizotinib contains thre...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07D213/73B01J19/00
CPCB01J19/0093C07D213/73
Inventor 任吉秋杨昆李海涛
Owner HEILONGJIANG XINCHUANG BIOLOGICAL TECH DEV CO LTD